Administration of 6-mercaptopurine to patients receiving the xanthine oxidase inhibitor allopurinol leads to significantly higher 6-mercaptopurine plasma concentrations.More extensive studies have found that it is the influence of allopurinol on gastrointestinal and hepatic xanthine oxidase that is most important, leading to a greater bioavailability of 6-mercaptopurine.
POST COMMENT
0 comments:
Post a Comment